Objective: Dilated cardiomyopathy (DCM) is a disorder featuring left ventricular dysfunction, heart failure, and a poor prognosis. The etiology is still unclear, despite diagnostic and therapeutic developments. This study was an evaluation of factors affecting the life span of a group of idiopathic DCM patients.
D ilated cardiomyopathy (DCM) is myocardial disease characterized by dilated left ventricular and systolic dysfunction, often coursing with congestive heart failure. The five-year mortality rate or heart transplantation requirement of these patients was reported as 46%. [1] It is the most common type of cardiomyopathy seen in children. The most common cause of DCM is idiopathic and followed by myocarditis. In the United States, annual the incidence of cardiomyopathy in the 0-18 age group is 1.13 per 100,000, and DCMs consist of half of these cases. In children aged under one year, the expected annual incidence of DCM is 4 per 100,000 children. [2] In epidemiological studies, the incidence in children was found to be 0.57-0.73/100.000. [3, 4] The prognosis of patients is in a wide spectrum ranging between sudden improvement and severe heart failure. [3] Due to the fact that drug treatment is not very effective, one third of the patients lead a mortal course or are candidates for heart transplantation. [4] The most frequency cause of heart transplantation in children is DCM. [5] Early diagnosis and treatment of DCM prevent or delay the development of heart failure. Intracardiac thrombosis is a common complication and a major cause of morbidity and mortality. The incidence of intracardiac thrombosis was found to be between 4-16% in patients with DCM. [6] [7] [8] [9] In this study we wanted to investigate the prognostic factors in patients with DCM.
METHODS
In our study, 79 patients with idiopathic DCM who were followed between October 2005 and October 2017 were evaluated retrospectively. The diagnosis of DCM was based on detection of expansion of ventricles and increase in left ventricular wall thickness along with systolic dysfunction detected in two-dimensional echocardiography in accordance with the recommendation of 2006 American Heart Association. [10] Secondary causes of DCM (infections, arrhythmias, endocrine diseases, neuromuscular diseases, rheumatologic and immunological diseases, nutritional deficiencies, conditions leading to ischemia, toxins and systemic diseases) were excluded.
Age and gender distribution, admission symptoms, physical examination, electrocardiography (ECG), telecardiography, echocardiography findings and prognosis were evaluated.
The age of onset of symptoms (<2 years and, ≥2 years), gender, consanguinity between parents, presence of cardiomegaly in the telecardiogram (0.60 in the neonatal period, 0.55 in the infancy and 0.50 in children) The effects of ejection fraction (EF) and shortening fraction (CF) measurements, left ventricular end-diastolic diameter (LVEDD), and intracardiac thrombosis on prognosis were investigated. The severity of mitral insufficiency was graded based on the extension of mitral regurgitation jet into left atrium as: Grade 1 <15%; Grade 2, 15-30%; Grade 3, 35-50%, and Grade 4, >50% grade 4 mitral regurgitation. [11] The survival of the patients were evaluated from the time of diagnosis.
Statistical analysis
The statistical analysis of the patients' data was performed with "SPSS, Chicago, IL, USA" program. "Survival (Therneau, 2015) package in R Studio" was used to draw the Kaplan-Meier curve. Mean ± standard deviation (SD) was used as descriptive statistics. P value <0.05 was considered significant. The survival times of the patients were evaluated using Kaplan-Meier method and Cox regression analysis. According to single-variable Cox regression results, variables with p<0.25 were selected as candidates for multiple Cox regression modeling.
RESULTS
The median age of 79 patients diagnosed with dilated cardiomyopathy was 20 months (10 days-198 months) while 40 (50.6%) patients were male and 39 (49.4%) of them were female. Forty-four (55.7%) patients were under, and 35 (44.3%) patients above two years of age Heart failure symptoms and signs were the most common cause of admission in both age groups (n=53, 67.1%). The most common physical examination findings were 2-3/6 degree systolic murmur heard at apical localization (n=53, 67.1%) and tachycardia (n=48, 60.4%). In 10 (12.6%) patients, In 30 (38%) patients consanguinity was observed between the parents including 10 patients whose parents. were first-degree relatives. The EF and SF values of the patients at the time of admission and at the end of the follow-up period are shown in Table 1 . In 4 (5.1%) patients, intracardiac thrombosis was detected which occurred in 3 patients at the time of their first admission and in 1 patient 2 months after the diagnosis (despite the antiaggregant prophylaxis).
EF and SF values of these patients were 25.5±5.9% and 12.2±2.6, respectively. Intracardiac thrombosis was seen in the left ventricle in four, and in the right ventricle in one patient. Two patients were treated with enoxaparin, one patient with heparin and the other one with tissue plasmin activator. None of the patients had a hematologic disorder that could lead to an arrhythmia or procoagulant condition. Demographic, clinical and echocardiographic features of the patients with thrombosis are shown in Table 2 . A retrospective elimination process was performed with multiple analysis. Three variables were left; Parental consanguinity (p=0.003), cardiomegaly in telecardiography (p=0.085) and low EF value (p=0.088) were found to be the most important factors in determining survival ( Table 4 ). The presence of cardiomegaly in the telecardiography and low EF were clinically significant, although not statistically significant, on survival. Because the risk of death was 3.67 times higher in patients with cardiomegaly, each 1 unit EF decreased the risk of death by 1.03 times. The survival curves of the patients are shown in Figure 1 Categorical risk factors were evaluated by KaplanMeier survival analysis using Log-Rank test (Table  5) . Numerical variables were evaluated by the proportional hazard regression method of univariate Cox analysis (Table 6 ).
DISCUSSION
The most frequent symptoms and signs of dilated cardiomyopathy are dyspnea, exercise intolerance, syncope, tachypnea, tachycardia and hepatomegaly. [12] Talierci et al. [13] found that heart failure was the most common (92%) finding in 24 patients with a mean age of two years.
In a study by Oh et al. [14] it was seen that the patients were admitted most frequently (67.1%) with signs and symptoms of heart failure. We found that 73.4% of our patients had cardiomegaly as detected in telecardiography.
In many studies, patients with a family history of CDM have been evaluated and it has been shown that patients have one or more relatives with CDM. [15] [16] [17] [18] Towbin et al. [1] reported the best 5-year survival rate of 94% in patients with family history of CDM.
The median follow-up period was 20 months (1-156) and 29 patients (36.7%) died during follow-up. Four (5.06%) patients underwent heart transplantation.
Fourteen patients (31.8%) aged <2 years and 15 (42.9%) patients aged ≥2 years exited. The mortality rate was found to be higher in female patients (n=16, 41%) than in male patients (n=13, 32.5%). Seventeen (56.7%) patients with and 12 (24.5%) patients without consanguineous parents exited. Twenty-seven (46.6%) patients with 2 (9.5%) patients without cardiomegaly as detected on telecardiography did not survive.
The mortality rate was 65.5% (n=19) in patients with mitral regurgitation at grade 2 and above (Table  3) . EF values of living and deceased patients were 38.6±12.6% and 30.7±11.1, respectively, while SF values were 18.6±6.7% and 15±5.6, respectively. However, in our country where the rate of consanguineous marriages is high, we think that family members should have detailed cardiological/echocardiographic examination and genetic studies if necessary.
The incidence of intracardiac thrombosis in children with dilated cardiomyopathy has been reported as 4-16% in various studies. [7, 19, 20] We found its incidence as 5.1% in our study population.
The incidence of thrombosis has been shown to increase up to 43-57% in autopsy studies. [20] [21] [22] When the effect of age on prognosis is evaluated, there are different results in the literature. Carvalho et al. [23] reported a worse prognosis in patients over two years of age. In the study performed by Kim et al., [24] age was not found to have an effect on prognosis. In our study, we found that age did not have any effect on mortality.
The relationship between gender of the patients and prognosis in patients with CDM has been evaluated, and in some studies female, in others, male gender was reported to be associated with poor prognosis. [15, 25] In our study we have not detected any effect of gender on prognosis.
Cardiomegaly and pulmonary edema are the most common findings in telecardiogram sof patients with dilated cardiomyopathy. [26] Increased cardiothoracic ratio is predictive of mortality. [27] In our study, it was found to be effective on mortality.
Taliercio et al. [13] reported lack of any relationship between left ventricular function and prognosis. Zecchin et al. [28] reported that patients with a longer LVEDD, who did not use beta-blockers and had a EF of less than 30% had a poor prognosis. McMahon et al. [29] reported a poorer prognosis for patients with
In our study, none of our patients had a family history of DCM. In our country, consanguineous marriages are still an important problem. The rate of kinship of parents of our patients was found to be 38 percent. Family members were evaluated echocardiographically in our study and no history of heart disease was reported. fore, it was thought that thrombosis was caused by low cardiac output, that is, stasis in blood flow. In studies performed especially in adult patients, it was observed that development of thrombosis was less frequent in patients with mitral regurgitation which was explained by the prevention of blood stasis in mitral regurgitation. [8, 31, 32] However, in another study, such a relationship could not be found. [19] Similarly, in our study, development of thrombosis was observed in our patients despite the presence of second and third degree mitral insufficiency. Any relationship between regurgitation and thrombosis could not be found. In pediatric patients with DCM, intracardiac thrombus is frequently localized in the left ventricle as was the case with our patients. Though rarely development of thrombosis has been reported in other cardiac chambers. [6, 7, 19, 30] Treatment of Intracardiac thrombosis is treated via medical [thrombolytic, anticoagulant] or surgical methods. [33, 34] thicker left ventricular posterior wall, longer LVEDD and low EF.
We found that EF and SF values of the deceased patients were significantly lower. However, we found no significant difference in the mortality rates in patients with a mortal course and a wider LVEDD compared with the survivors.
Another factor effective on prognosis is the development of intracardiac thrombosis.
In our study, we found that the prognosis of our patients with intracardiac thrombosis was not statistically worse. We thought that this result may be related to our limited number of patients. In the etiology of intracardiac thrombosis in children lower cardiac output, arrhythmia, and hematological diseases which result in hypercapulopathy are shown as three main etiologic factors. [6, 19, 30] Our patients did not have an etiologic factor or arrhythmia that could cause hypercoagulopathy. There- There is no precise information about the choice of treatment options in children. Medical treatment has a tendency to treat small thromboembolism. However, as is shown, morphology of the thrombi has not an effective factor on the risk of embolism. [30] If a patient with CDM has SF less than 20%, then it is recommended to start intensive anticoagulant therapy if the patient has a history of stroke and/or if an intracardiac thrombus is observed. [7, 19] Günthard et al. [6] suggested initiation of intravenous heparin or oral anticoagulant therapy when an intracardiac thrombus is observed. CDM patients with large thrombi need thrombolytic therapy. Thrombolytic therapy was started in one of our patients because thrombus was very large (40x25 mm).
In patients with dilated cardiomyopathy, the prognosis is poor despite medical treatment. Heart transplantation should be considered in patients with multiple organ failure and require treatment with mechanical ventilator despite medical treatment. [26] In our study, heart transplantation was performed in four (5%) patients. The mortality rate has been reported to be between 11.5 and 26.9% in the studies performed. In our study, the mortality rate in our patients was found to be 36.7 percent.
In conclusion, the main factors affecting mortality and five-year survival in patients with DCM have been found as kinship marriages, detection of cardiomegaly in telecardiograms at the time of diagnosis, and lower EF and SF values, and higher grades of mitral regurgitation in echocardiography. 
